Lenox Hill Hospital is a nationally ranked 450-bed non-profit, tertiary, research and academic medical center located at the Upper East Side of Manhattan, New York City, servicing the tri-state area. LHH is one of the region's many university-level academic medical centers.

There are 449 beds in Lenox Hill Hospital.

During the past decade, Lenox Hill Hospital conducted 128 clinical trials. In the 10-year time frame, 128 clinical trials started and 34 clinical trials were completed, i.e. on average, 26.6% percent of trials that started reached the finish line to date. In the past 5 years, 61 clinical trials started and 21 clinical trials were completed. i.e. 34.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Lenox Hill Hospital" #1 sponsor was "Northwell Health" with 20 trials, followed by "Abbott Medical Devices" with 12 trials sponsored, "Boston Scientific Corporation" with 11 trials sponsored, "Medtronic Cardiovascular" with 7 trials sponsored and "Boehringer Ingelheim" with 7 trials sponsored. Other sponsors include 133 different institutions and companies that sponsored additional 108 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Lenox Hill Hospital" #1 collaborator was "National Cancer Institute (NCI)" with 13 trials as a collaborator, "Lenox Hill Hospital" with 3 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 3 trials as a collaborator, "Northwell Health" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 80 different institutions and companies that were collaborators in the rest 81 trials.

According to Clinical.Site data, the most researched conditions in "Lenox Hill Hospital" are "Coronary Artery Disease" (18 trials), "Atrial Fibrillation" (11 trials), "Heart Failure" (8 trials), "Crohn's Disease" (7 trials) and "Crohn Disease" (6 trials). Many other conditions were trialed in "Lenox Hill Hospital" in a lesser frequency.

Most popular intervention types in "Lenox Hill Hospital" are "Device" (87 trials), "Drug" (73 trials), "Other" (33 trials), "Procedure" (25 trials) and "Biological" (11 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (21 trials), "Laboratory Biomarker Analysis" (6 trials), "Quality-of-Life Assessment" (6 trials), "Computed Tomography" (4 trials) and "Medtronic CoreValve® System Transcatheter Aortic Valve Implantation (TAVI)" (4 trials). Other intervention names were less common.

The vast majority of trials in "Lenox Hill Hospital" are 183 trials for "All" genders, 9 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are 79 active trials in "Lenox Hill Hospital". 1 are not yet recruiting, 52 are recruiting, 25 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 81 completed trials in Lenox Hill Hospital, 1 suspended trials, and 20 terminated clinical trials to date.

Out of the total trials that were conducted in Lenox Hill Hospital, 9 "Phase 1" clinical trials were conducted, 34 "Phase 2" clinical trials and 50 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 8 trials, and there were also 70 trials that are defined as “Not Applicable".